These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20137334)
1. [Thrombolysis of rabbit's pulmonary embolism with thrombus-targeted urokinase immune liposome]. Lü CP; Yang H; Wang J; Dong XL Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Nov; 37(11):1035-8. PubMed ID: 20137334 [TBL] [Abstract][Full Text] [Related]
2. [Preparation of thrombus-targeted urokinase liposomes and its thrombolytic effect in model rats]. Wang XT; Li S; Zhang XB; Hou XP Yao Xue Xue Bao; 2003 Mar; 38(3):231-5. PubMed ID: 12830724 [TBL] [Abstract][Full Text] [Related]
3. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase. Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163 [TBL] [Abstract][Full Text] [Related]
4. Combined catheter thrombus fragmentation and fibrinolysis for acute pulmonary embolism. Gao H; Huang GY; Ma LL; Wang LX Intern Med J; 2011 Sep; 41(9):687-91. PubMed ID: 21899681 [TBL] [Abstract][Full Text] [Related]
5. Lung endothelium targeting for pulmonary embolism thrombolysis. Ding BS; Zhou YJ; Chen XY; Zhang J; Zhang PX; Sun ZY; Tan XY; Liu JN Circulation; 2003 Dec; 108(23):2892-8. PubMed ID: 14610017 [TBL] [Abstract][Full Text] [Related]
6. Effect of low-molecular-weight heparin and urokinase on pulmonary arteries involved in pulmonary embolism. Wu JP; Sun X; Wu Q; DU ZZ; Li L; Wu Q; Sun HF Chin Med J (Engl); 2013 Jun; 126(12):2254-9. PubMed ID: 23786934 [TBL] [Abstract][Full Text] [Related]
7. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism]. Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator. Kurokawa T; Iwasa S; Kakinuma A; Stassen JM; Lijnen HR; Collen D Thromb Haemost; 1991 Dec; 66(6):684-93. PubMed ID: 1796414 [TBL] [Abstract][Full Text] [Related]
9. [The effect of low molecular heparin and urokinase on MCP-1 of acute experimental pulmonary embolism in rabbits]. Yu H; Wu Q; Wu J; Sun X; Du Z; Li L; Wu Q Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):437-41. PubMed ID: 25200044 [TBL] [Abstract][Full Text] [Related]
10. The effects of thrombus, thrombectomy and thrombolysis on endothelial function. Reil TD; Moore WS; Kashyap VS; Nene SS; Gelabert HA; Quinones-Baldrich WJ Eur J Vasc Endovasc Surg; 2000 Feb; 19(2):162-8. PubMed ID: 10727365 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of aspiration of pulmonary emboli and prolonged local thrombolysis to treat pulmonary embolism. Cuculi F; Kobza R; Bergner M; Erne P Am J Cardiol; 2012 Dec; 110(12):1841-5. PubMed ID: 22980966 [TBL] [Abstract][Full Text] [Related]
12. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis. Collen D; Stassen JM; Blaber M; Winkler M; Verstraete M Thromb Haemost; 1984 Aug; 52(1):27-30. PubMed ID: 6541817 [TBL] [Abstract][Full Text] [Related]
13. Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator. Prewitt RM; Hoy C; Kong A; Gu SA; Greenberg D; Cook R; Chan SM; Ducas J Am Rev Respir Dis; 1990 Feb; 141(2):290-5. PubMed ID: 2105682 [TBL] [Abstract][Full Text] [Related]
14. [Increased thrombolysis and decreased platelet aggregation with an anti-GPIIb/IIIa antibody urokinase hybrid molecule (7E3-UK)]. Bode C; Nordt T; Freitag M; Ruef J; Kaltenmeier M; Meinhardt G; Kübler W; Haber E Verh Dtsch Ges Inn Med; 1991; 97():1-2. PubMed ID: 1839701 [No Abstract] [Full Text] [Related]
15. Acute Massive Pulmonary Thromboembolism Treated by Selective Catheter-Directed Thrombolysis. Hai F; Xueming C; Zhiwen Z; Chenyu L; Jie F; Zhe Z; Lishan L; Renming Z; Hongzhi Y; Bin L Ann Vasc Surg; 2018 Jul; 50():8-14. PubMed ID: 29455018 [TBL] [Abstract][Full Text] [Related]
16. [Experimental study of the thrombolytic effects in a canine model of pulmonary thromboembolism induced by autologous radioactive blood clots]. Wang F; Wang C; Wang T; Pang BS; Wu YB; Yang YH; Li C; Zhang HY; Weng XZ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):93-6. PubMed ID: 14990182 [TBL] [Abstract][Full Text] [Related]
17. Massive pulmonary embolism: what level of aggression? Konstantinides SV Semin Respir Crit Care Med; 2008 Feb; 29(1):47-55. PubMed ID: 18302086 [TBL] [Abstract][Full Text] [Related]
19. [The value of thrombolysis for the treatment of acute pulmonary embolism]. Marbet GA Schweiz Med Wochenschr; 1989 Oct; 119(43):1498-505. PubMed ID: 2514456 [TBL] [Abstract][Full Text] [Related]
20. [Chronic effects of 100 mg/2 hours recombinant tissue-type plasminogen activator therapy regimen for patients with acute pulmonary thromboembolism]. Li ZP; Xu B; Jiang R; Li JL; Jiang X; Sun ML; Jing ZC; Li YP Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):224-8. PubMed ID: 23879948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]